Arrowstreet Capital’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-41,642
| Closed | -$3.11M | – | 1290 |
|
|
2021
Q4 | $3.11M | Buy |
+41,642
| New | +$3.11M | ﹤0.01% | 925 |
|
|
2021
Q2 | – | Sell |
-8,400
| Closed | -$414K | – | 1971 |
|
|
2021
Q1 | $414K | Sell |
8,400
-8,831
| -51% | -$435K | ﹤0.01% | 2043 |
|
|
2020
Q4 | $725K | Buy |
17,231
+12,231
| +245% | +$515K | ﹤0.01% | 1915 |
|
|
2020
Q3 | $229K | Buy |
+5,000
| New | +$229K | ﹤0.01% | 2180 |
|
|
2020
Q1 | – | Sell |
-8,000
| Closed | -$494K | – | 1931 |
|
|
2019
Q4 | $494K | Buy |
+8,000
| New | +$494K | ﹤0.01% | 1491 |
|
|
2019
Q1 | – | Sell |
-6,800
| Closed | -$482K | – | 1772 |
|
|
2018
Q4 | $482K | Buy |
+6,800
| New | +$482K | ﹤0.01% | 1096 |
|
|
2018
Q2 | – | Sell |
-50,694
| Closed | -$4.1M | – | 1136 |
|
|
2018
Q1 | $4.1M | Buy |
50,694
+30,404
| +150% | +$2.46M | 0.01% | 614 |
|
|
2017
Q4 | $1.19M | Buy |
+20,290
| New | +$1.19M | ﹤0.01% | 929 |
|
|
2016
Q4 | – | Sell |
-16,600
| Closed | -$442K | – | 1883 |
|
|
2016
Q3 | $442K | Buy |
+16,600
| New | +$442K | ﹤0.01% | 1279 |
|
|
2014
Q4 | – | Sell |
-15,322
| Closed | -$606K | – | 1255 |
|
|
2014
Q3 | $606K | Sell |
15,322
-25,675
| -63% | -$1.02M | ﹤0.01% | 803 |
|
|
2014
Q2 | $1.77M | Sell |
40,997
-18,710
| -31% | -$806K | 0.01% | 620 |
|
|
2014
Q1 | $2.39M | Buy |
+59,707
| New | +$2.39M | 0.01% | 617 |
|